Treatment Details
Molnupiravir
0
Effectiveness
0
Side Effects
0
Cost
4
Relevant Research Studies
Most-Reviewed Use: ANTIBIOTICS
Ratings
0 Comments
27 Views
Brand Name: Lagevrio
Drug Class: Nuceloside analog
FDA Category: Prescription Medication
CompendiRx Topic(s): Antivirals and Antibiotics
Dosage Form: Tablet Capsule - 200mg
Common Usage: COVID-19 infection
How it works
Inhibits viral replication by promoting mutations in the RNA of viruses
Pregnancy
There are no available human data on the use of LAGEVRIO in pregnant individuals to evaluate the risk of major birth defects, miscarriage or adverse maternal or fetal outcomes; therefore, LAGEVRIO is not recommended during pregnancy
Lactation
Based on the potential for adverse reactions in the infant from LAGEVRIO, breastfeeding is not recommended during treatment with LAGEVRIO and for 4 days after the final dose
Warnings
Warnings: Hypersensitivity, not recommended for those less than 18 due to bone and cartilage toxicity
Write a Review
© 2024 CompendiRx.com. All Rights Reserved. Information on Ratings and Reviews is reported by our members and is not medical advice.
Submission Date: Apr 16, 2024, 08:01AM
Last Update Date: Jul 27, 2024, 09:24PM
![](https://staging.compendirx.com/wp-content/themes/medical-directory-child/assets/img/insta.png")
© 2024 CompendiRx.com. All Rights Reserved. Information on Ratings and Reviews is reported by our members and is not medical advice.
Related Medicines